Skip to main content
SpringerLink
Log in

Climacteric symptoms and hormonal replacement therapy: A risk or an opportunity?

  • Gastvorlesung/Conférence magistrale
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bain C, Willett W, Hennekens CH, Rosner B, Belanger C, Speizer FE (1981) Use of postmenopausal hormones and risk of myocardial infarction. Circulation 65:42–46

    Google Scholar 

  2. Barrett-Connor E, Bush TL (1991) Estrogen and coronary heart disease in women. JAMA 265:1861–1867

    CAS  PubMed  Google Scholar 

  3. Bergkvist L, Adami HO, Persson I, Hoover R, Schairer C (1989) The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med 321:392–397

    Google Scholar 

  4. Bush T, Cowan L, Heiss G, Chambliss L, Wallace R (1984) Ovarian function and lipid/lipoprotein levels: results from the Lipid Research Clinics Program. Am J Epidemiol 120:489

    Google Scholar 

  5. Bush T, Barrett-Connor E, Cowan L et al. (1987) Cardiovascular mortality and non-contraceptive estrogen use in women: results from the Lipid Research Clinics' Program Follow-Up Study. Circulation 75:1102–1109

    CAS  PubMed  Google Scholar 

  6. Hammar M, Berg G, Farhaeus L, Larsson-Cohn U (1984) Climacteric symptoms in unselected sample of Swedish women. Maturitas 6:345–350

    Article  CAS  PubMed  Google Scholar 

  7. Hillard T, Bourne T, Whitehead M, Crayford T, Collins W, Campbell S (1992) Differential effects of transdermal estradiol and sequential progestogens on impedance to flow within the uterine arteries of postmenopausal women. Fertility and Sterility 58:959–963

    CAS  PubMed  Google Scholar 

  8. Jaszmann L (1976) Epidemiology of climacteric syndrome. In: Campbell S (ed) The management of the menopause and postmenopausal years. MTP Press, Lancaster, pp 11–23

    Google Scholar 

  9. Jensen J, Nilas L, Christiansen C (1990) Influence of menopause on serum lipids and lipoproteins. Maturitas 12:321–331

    Article  CAS  PubMed  Google Scholar 

  10. Kannel W, Hjortland MC, McNamara PM, Gordon T (1976) Menopause a risk of cardiovascular disease: The Framingham Study. Ann Intern Med 85:447–452

    CAS  PubMed  Google Scholar 

  11. Lapidus L, Bengtsson C, Lindquist O, Sigurdsson JA, Rybo E (1985) Triglycerides main lipid risk factor for cardiovascular disease in women? Acta Med Scand 217:481–489

    CAS  PubMed  Google Scholar 

  12. Lindgren R, Berg G, Hammar M, Larsson-Cohn U, Olsson AG (1992) Plasma lipid and lipoprotein effects of transdermal administration of estradiol and estradiol/norethisterone acetate. Eur J Obstet Gynecol Reprod Biol 47:213–221

    Article  CAS  PubMed  Google Scholar 

  13. Lindgren R, Risberg B, Hammar M, Berg G, Pryse-Davies J (1992) Endometrial effects of transdermal estradiol/norethisterone acetate. Maturitas 15:71–78

    Article  CAS  PubMed  Google Scholar 

  14. Lindquist O, Bengtsson C (1980) Serum lipids, arterial blood pressure and body weight in relation to the menopause. Results from a population study of women in Göteborg, Sweden. Scand J Clin Lab Invest 40:629–636

    CAS  PubMed  Google Scholar 

  15. The Lipid Research Clinics Program (1984) The Lipid Research Clinics coronary primary prevention trial results. I. Reduction in incidence of coronary heart disease. JAMA 251:351–364

    Google Scholar 

  16. McKinlay SM, Brambilla DJ, Posner JG (1992) The normal menopause transition. Maturitas 14:103–115

    Article  CAS  PubMed  Google Scholar 

  17. Neugarten BL, Kraines RJ (1965) “Menopausal symptoms” in women of various ages. Psychosomatic Med 27:266–273

    CAS  Google Scholar 

  18. Notelovitz M (1986) Climacteric medicine and science: a societal need. In: Notelovitz M, van Keep P (eds) The climacteric in perspective. MTP Press, Lancaster, pp 19–22

    Google Scholar 

  19. Oldenhave A (1990) Hot flushes and their relation to other symptoms: results from the third Ene study in The Netherlands. Sixth International Congress on the Menopause, Bangkok, November 1990 (Abstract No. 093)

  20. Peterson H, Lee N, Rubin G (1987) Genital Neoplasi. In: Mishell D (eds) Menopause, physiology and pharmacology. Year Book Medical, Chicago, pp 275–289

    Google Scholar 

  21. Ross PK, Paganini-Hill A, Mack TM, Arthur M, Henderson BE (1981) Menopausal oestrogen therapy and protection from death from ischemic heart disease. Lancet i:858–860

    Google Scholar 

  22. Samsioe G (1991) Cardiovascular disease and lipid metabolism: the influence of HRT. In: Utian WH, Riggs BL, Samsioe G (eds) Long-term HRT, perceptions and realities. Parthenon, Carnforth, pp 17–24

    Google Scholar 

  23. Stampfer MJ, Willett WC, Colditz GA et al. (1985) A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med 313:1044–1049

    CAS  PubMed  Google Scholar 

  24. Steinberg KK, Thacher SB, Smith SJ et al. (1991) A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. JAMA 265/15:1985–1990

    Article  CAS  PubMed  Google Scholar 

  25. Studd JW, Thom MH, Peterson MEL, Wade-Evans T (1980) The prevention and treatment of endometrial pathology in postmenopausal women receiving exogenous estrogens. In: Pasetto N, Paoletti R, Ambrus J (eds) The menopause and postmenopause. MTP Press, Lancaster, pp 127–139

    Google Scholar 

  26. Sullivan JM, Zwagg RV, Lemp GF et al. (1988) Postmenopausal estrogen use and coronary atherosclerosis. Ann Intern Med 108:358–363

    CAS  PubMed  Google Scholar 

  27. Whitehead MI, King RJB, McQueen J, Campbell S (1979) Endometrial histology and biochemistry in climacteric women during estrogen and estrogen/progestagen therapy. J R Soc Med 72:322–327

    CAS  PubMed  Google Scholar 

  28. Whitehead MI, Townsend PT, Pryse-Davies J, Ryder TA, King RJB (1981) Effects of estrogens and progestins on the biochemistry and morphology of the postmenopausal endometrium. N Engl J Med 305:1599–1605

    CAS  PubMed  Google Scholar 

  29. WHO Scientific Group on Research on the Menopause (1981) Research on the menopause. WHO Technical Report, p 670

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, University Hospital, S-58185, Linköping, Sweden

    R. Lindgren

Authors
  1. R. Lindgren
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lindgren, R. Climacteric symptoms and hormonal replacement therapy: A risk or an opportunity?. Arch Gynecol Obstet 253 (Suppl 1), S45–S49 (1993). https://doi.org/10.1007/BF02346796

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02346796

Keywords

Search

Navigation